Your browser doesn't support javascript.
loading
A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy.
Won, Young-Woong; Kang, Jin-Hyoung; Kwon, Jung Hye; Koo, Dong-Hoe; Kang, Jung Hun; Maeng, Chi Hoon; Ahn, Hee Kyung; Oh, Sung Yong; Lee, Dae-Won; Sohn, Joohyuk; Oh, So Yeon; Lee, Kyung Hee; Koh, Su-Jin; Lee, Keun Seok; Kim, Chan-Kyu; Kim, Ji-Yeon; Ji, Jun Ho; Kim, Sung-Bae; Ha, Joo Young; Kim, Ho Young.
Afiliación
  • Won YW; Division of Hematology and Oncology, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
  • Kang JH; Division of Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Kwon JH; Division of Hematology and Oncology, Department of Internal Medicine, Chungnam National University Sejong Hospital, Chungnam National University College of Medicine, Sejong, Korea.
  • Koo DH; Division of Hematology/Oncology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kang JH; Division of Hematology and Oncology, Department of Internal Medicine, Gyeongsang National University College of Medicine, Jinju, Korea.
  • Maeng CH; Division of Oncology and Hematology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea.
  • Ahn HK; Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
  • Oh SY; Division of Hematology and Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
  • Lee DW; Division of Hematology and Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Sohn J; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Oh SY; Division of Hematology and Oncology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan University College of Medicine, Yangsan, Korea.
  • Lee KH; Division of Hematology and Oncology, Department of Internal Medicine, Yeungnam University Hospital, Yeungnam University College of Medicine, Daegu, Korea.
  • Koh SJ; Division of Hematology and Oncology, Department of Internal Medicine, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, Korea.
  • Lee KS; Center for Breast Cancer, Research Institute, National Cancer Center, Goyang, Korea.
  • Kim CK; Division of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Hospital Bucheon, Soonchunhyang University College of Medicine, Bucheon, Korea.
  • Kim JY; Division of Hematology and Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Ji JH; Division of Hematology and Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
  • Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Ha JY; Division of Hematology and Oncology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
  • Kim HY; Division of Hematology and Oncology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.
Cancer Res Treat ; 55(4): 1096-1103, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37054719

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Cancer Res Treat Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Cancer Res Treat Año: 2023 Tipo del documento: Article